A novel chimeric decoy receptor VF-Trap fusion protein that binds both VEGF and bFGF was developed by Li et al. to simultaneously block activity of both VEGF and bFGF pathways and achieve an additive anti-tumor effect. This evidence concerns the gene FGF2 and neoplasm.